CJC1295 Peptide (With and Without DAC) Supplier China | China Factory Bulk Supply & COA Verified Material
Price range: $88.00 through $180.00 / box (10 vials) Shipping: $97 per order | Free shipping on orders over $600
≥98% HPLC Verified | Direct China Peptide Manufacturer | COA PDF Available
- CJC1295 without DAC
- CJC1295 with DAC
- CJC1295+IPA
DOWNLOAD COA CJC1295 WITHOUT DAC
Overview
CJC1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied exclusively for laboratory research and analytical applications. Due to its modified peptide structure and extended biological stability, CJC1295 is widely referenced in scientific literature for peptide chemistry, receptor interaction studies, analytical method development, pharmacokinetic investigations, and preclinical experimental research.
RPL Peptide manufactures research-grade CJC1295 using controlled Solid Phase Peptide Synthesis (SPPS), followed by chromatographic purification and comprehensive analytical verification. Every production batch is accompanied by a Certificate of Analysis (COA), chromatographic purity testing, identity confirmation, and complete batch traceability to satisfy the procurement requirements of biotechnology companies, universities, pharmaceutical research organizations, contract laboratories, and scientific distributors worldwide.
This product is supplied exclusively for laboratory research and analytical purposes. It is not intended for human or veterinary use.
Product Overview
CJC1295 is a synthetic peptide derived from Growth Hormone-Releasing Hormone (GHRH). It has been extensively described in scientific literature as a research peptide suitable for receptor-binding investigations, peptide stability studies, analytical characterization, and laboratory method development. Depending on research objectives, scientific publications reference both CJC1295 DAC (Drug Affinity Complex) and Modified GRF (1-29) variants for experimental investigations.
Research-grade CJC1295 supplied by RPL Peptide is manufactured under documented quality systems using validated peptide synthesis and analytical testing procedures. Each production lot undergoes chromatographic purity analysis, molecular identity verification, and rigorous quality review before release to ensure consistent performance in laboratory environments.
Technical Specifications
| Parameter | Specification (With DAC Variant) | Specification (Without DAC Variant) | Specification (CJC1295 + IPA Blend) |
| Product Name | CJC-1295 with DAC Peptide | CJC-1295 without DAC | CJC-1295 + Ipamorelin Blend |
| Synonyms | Tetrasubstituted GHRH (with DAC) | Modified GRF (1-29), Mod GRF 1-29 | CJC1295 / Ipamorelin Research Combination |
| CAS Number | 863288-34-0 | 446030-75-3 | N/A (Dual Peptide Formulation) |
| Sequence Length | 30 Amino Acids | 29 Amino Acids | 29 AA (Mod GRF) + 5 AA (Ipamorelin) |
| Molecular Formula | $C_{165}H_{271}N_{47}O_{48}$ | $C_{165}H_{269}N_{47}O_{46}$ | Multi-component mixture |
| Molecular Weight | 3649.30 Da | 3367.97 Da | 3367.97 Da + 711.86 Da |
| Purity Grade | ≥98% (RP-HPLC) | ≥98% (RP-HPLC) | Total Peptide Purity ≥98% |
Chemical Identity & Key Characteristics
CJC1295 is classified as a synthetic research peptide manufactured for scientific investigations involving peptide chemistry, analytical testing, and receptor biology. Research-grade material is produced with high purity and verified analytical identity suitable for laboratory procurement.
Key characteristics include:
- Synthetic research peptide
- High-purity lyophilized powder
- Growth Hormone-Releasing Hormone (GHRH) analogue
- Suitable for analytical chemistry research
- RP-HPLC purity verification
- LC-MS molecular identity confirmation
- COA available for qualified production batches
- Batch-controlled manufacturing
- High manufacturing consistency for laboratory procurement
Manufacturing & Analytical Verification
Research-grade CJC1295 is produced using Solid Phase Peptide Synthesis (SPPS), followed by purification and analytical verification prior to final batch release.
Quality assurance procedures typically include:
- Solid Phase Peptide Synthesis (SPPS)
- Preparative purification
- RP-HPLC purity analysis
- LC-MS molecular identity verification
- UPLC analysis where applicable
- Batch release review
- Certificate of Analysis (COA)
- Complete batch traceability documentation
Every production lot is manufactured under documented quality procedures to ensure reproducibility across research applications.
Research Applications
Research-grade CJC1295 is commonly supplied for laboratory investigations involving:
- Peptide analytical research
- GHRH receptor studies
- Peptide characterization
- Stability studies
- Pharmacokinetic investigations
- Analytical method development
- Reference standard evaluation
- Biochemical research
- Cell-based experimental studies
- Academic research
- Preclinical investigations described in scientific literature
This material is supplied exclusively for laboratory research and analytical applications.
Procurement Considerations
When selecting a CJC1295 manufacturer, laboratories typically evaluate peptide purity, analytical verification, Certificate of Analysis availability, manufacturing consistency, production scalability, OEM capability, batch traceability, and long-term supply reliability.
RPL Peptide supports global research procurement by supplying research-grade CJC1295 accompanied by comprehensive analytical documentation and batch identification records suitable for:
- Biotechnology companies
- Universities
- Pharmaceutical research organizations
- Contract research laboratories
- Scientific distributors
- Research reagent suppliers
Packaging & Storage
Packaging Options
- 2 mg/vial
- 5 mg/vial
- 10 mg/vial
- Custom fill quantities available upon request
- OEM labeling and packaging supported
Storage Recommendations
- Store at 2–8°C for short-term storage.
- Store at -20°C for long-term storage.
- Protect from moisture, excessive heat, and repeated freeze-thaw cycles.
- Handle according to established laboratory procedures.
Frequently Asked Questions
What is CJC1295?
CJC1295 is a synthetic Growth Hormone-Releasing Hormone (GHRH) analogue supplied for laboratory research, peptide characterization, and analytical applications.
What is CJC1295 used for in research?
Research-grade CJC1295 is commonly utilized for receptor interaction studies, peptide characterization, analytical chemistry, stability studies, pharmacokinetic investigations, and laboratory method development. Scientific literature also describes its investigation in various preclinical experimental models.
What purity standard is provided?
Research-grade CJC1295 is typically supplied with ≥98% purity verified by RP-HPLC analytical testing.
How is product identity verified?
Each production batch undergoes LC-MS molecular identity confirmation together with RP-HPLC purity analysis and, where applicable, UPLC verification.
Is a Certificate of Analysis available?
Yes. Every qualified production batch is supplied with a Certificate of Analysis (COA) together with supporting analytical documentation.
How is manufacturing consistency maintained?
Each production lot follows documented peptide synthesis procedures, standardized quality control protocols, chromatographic verification, and complete batch traceability before release.
Can bulk and OEM orders be supported?
Yes. RPL Peptide supports bulk supply, OEM packaging, private labeling, custom milligram fills, and long-term manufacturing partnerships for qualified research procurement.
Who purchases research-grade CJC1295?
Typical customers include biotechnology companies, universities, pharmaceutical research organizations, contract laboratories, scientific distributors, and peptide research suppliers worldwide.
Is this product intended for human use?
No. This product is supplied exclusively for laboratory research and analytical purposes and is not intended for human or veterinary use.
| Size | Without DAC 5mg, Without DAC 10mg, With DAC 5mg, CJC1295 5mg+IPA 5mg, CJC1295 10mg+ IPA 10mg |
|---|









